Using real-world data and evidence provides essential insights into the safety, effectiveness, and wider effects of therapies outside of controlled clinical settings. This is especially important in an era where precision medicine and patient-centred methods are becoming increasingly popular.

While RWE has a lot of potential, the industry must overcome perceptions from industry relating to randomization, data quality, and the potential for false results due to missing data.

This panel will discuss how to harness the full potential of RWD/RWE to drive innovation in clinical trial designs, to improve patient outcomes and advance healthcare delivery.